文献リスト

1) Parkin DM, Bray F, Ferlay J, et al. Global cancer stastics, 2002. CA Cancer J Clin. 2005; 55: 74-108

2) Koo LC, Ho JH-C. Worldwide epidemiological patterns of lung cancer in non smokers. Int J Epidemiol. 1990; 19: s14-s23

3) Tyczynski JE, Bray F, Parkin DM. Lung cancer in Europe in 2000: Epidemiology, prevention, and early detection. Lancet Oncol. 2003; 4: 45-55

4) Ou SI, Ziogas A, Zell JA. Epidemiology study of never-smokers with non-small cell lung cancer (NSCLC): High percentages of Asian and Hispanic female never-smokers and the significance of Asian ethnicity. J Clin Oncol. 2008; 26: 15S(suppl)

5) Subramanian J, Govindan R. Lung cancer in never smokers: A review. J Clin Oncol. 2007; 25: 561-70

6) Fontham ET, Correa P, Reynolds P, et al. Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study. JAMA. 1994; 271: 1752-9

7) Toh CK, Gao F, Lim WT, et al. Never-smokers with lung cancer: Epidemiologic evidence of a distinct disease entity. J Clin Oncol. 2006; 24: 2245-51

8) Yu IT, Chiu YL, Au JS, et al. Dose-response relationship between cooking fumes exposures and lung cancer among Chinese nonsmoking women. Cancer Res. 2006; 66: 4961-7

9) Boffetta P, Agudo A, Ahrens W, et al. Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst. 1998; 90: 1440-50

10) Wakelee HA, Chang ET, Gomez SI, et al. Lung cancer incidence in never smokers. J Clin Oncol. 2007; 25: 472-8

11) Hirayama T. Non-smoking wives of heavy smokers have a higher risk of lung cancer: A study from Japan. Br Med J (Clin Res Ed). 1981; 282: 183-5

12) Vineis P, Alavanja M, Buffler P, et al. Tabacco and cancer: Recent epidemiological evidence. J Natl Cancer Inst. 2004; 96: 99-106

13) U. S. Department of Health and Human Services. The health effects of involunmtary exposure to tobacco smoke. In: USDHHS (U. S. Department of Health and Human Services), editor. 2006; Centers for Disease Control and Prevention (CDC)

14) Bennett WP, Alavanja MC, Blomeke B, et al. Environment tobacco smoke, genetic susceptibility, and lung cancer in never-smoking women. J Natl Cancer Inst. 1999; 91: 2009-14

15) Kiyohara C, Wakai K, Mikami H, et al. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women. Int J Cancer. 2003; 107: 139-44

16) Gao YT, Blot WJ, Zheng W, et al. Lung cancer among Chinese women. Int J Cancer. 1987; 40: 604-9

17) Doll R. Mortality from lung cancer in asbestos workers. Br J Ind Med. 1955; 12: 81-6

18) Magnani C, Leporati M. Mortality from lung cancer and population risk attributable to asbestos in an asbestos cement manufacturing town in Italy. Occup Environ Med. 1998; 55: 111-4

19) Pershagen G, Wall S, Taube A, et al. On the interaction between occupational arsenic exposure and smoking and its relationship to lung cancer. Scand J Work Environ Health. 1981; 7: 302-9

20) Tsuda T, Nagira T, Yamamoto M, et al. An epidemiological study on cancer in certified arsenic poisoning patients in Toroku. Ind Health. 1990; 28: 53-62

21) Alvanja M, Brownson R, Boice J Jr, et al. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol. 1992; 136: 623-32

22) Cheng YW, Chiou HL, Chen JT, et al. Gender difference in human papillomavirus infection for non-small cell lung cancer in Taiwan. Lung Cancer. 2004; 46: 165-70

23) Cheng Y-W, Chiou HL, Sheu G-T, et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 2001; 61: 2799-803

24) Engels EA, Brock MV, Ghen J, et al. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol. 2006; 24: 1383-8

25) World Cancer Research Fund International. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington: American Institute for Cancer Research; 2007

26) Mulder I, Jansen MC, Smit HA, et al. Role of smoking and diet in the cross-cultural variation in lung-cancer mortality: the Seven Countries Study. Seven Countries Study Research Group. Int J Cancer. 2000; 88: 665-71

27) Koo LC. Dietary habits and lung cancer risk among Chinese females in Hong Kong who never smoked. Nutr Cancer. 1988; 11: 155-72

28) Ozasa K, Watanabe Y, Ito Y, et al. Dietary habits and risk of lung cancer death in a large-scale cohort study (JACC study) in Japan by sex and smoking habit. Jpn J Cancer Res. 2001; 92: 1259-69

29) Tokuhata GK, Lillienfield AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst. 1963; 30: 289-312

30) Ooi W, Elston R, Chen V, et al. Increased familial risk for lung cancer. J Natl Cancer Inst. 1986; 76: 217-22

31) Wenzlaff AS, Cote ML, Bock CH, et al. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study. Carcinogenesis. 2005; 26: 395-401

32) Bonner MR, Bennett WP, Xiong W, et al. Radon, secondhand smoke, glutathione-S-transferase M1 and lung cancer among women. Int J Cancer. 2006; 119: 1462-7

33) Le Marchand L, Guo C, Benhamou S, et al. Pooled analysis of CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control. 2003; 14: 339-46

34) Shigematsu H, Lin L, Takahashi T, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst. 2005; 97: 339-46

35) Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancer. Int J Cancer. 2006; 118: 257-62

36) Rudin CM, Avila-Tang E, Harris CC, et al. Lung cancer in never smokers: Molecular profiles and therapeutic implications. Clin Cancer Res. 2009; 15: 5646-61

37) Thatcher N, Chang A, Parikh P, et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomized, placebo-controlled, multicentre study (Iressa Survical Evaluation in Lung Cancer). Lancet. 2005; 366: 1527-37

38) Herbst RS, Prager D, Hermann R, et al. TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol. 2005; 23: 5892-9

39) Ahrendt SA, Decker PA, Aiawi EA, et al. Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer. 2001; 92: 1525-30

40) Soda M, Choi YI, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007; 448: 561-6

41) Wong DW, Leung EL, So KK, et al. The EML4-ALK fusion gene in involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer. 2009; 115: 1723-33

42) Takahashi T, Nau MM, Chiba I, et al. p53: A frequent target for genetic abnormarlities in lung cancer. Science. 1989; 246: 491-4

43) Toyooka S, Tsuda T, Gazdar AF: The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat. 2003; 21: 229-39

44) Wong MP, Fung LF, Wang E, et al. Chromosomal aberrations of primary lung adenocarcinomas in nonsmokers. Cancer Epidemiol Biomarkers Prev. 2003; 97: 1263-70

45) Toyooka S, Maruyama R, Toyooka KO, et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer. 2003; 103: 153-60

46) Toyooka S, Suzuki M, Tsuda T, et al. Dose effect of smoking on aberrant methylation in non-small cell lung cancers. Int J Cancer. 2004; 110: 462-4

47) Wang Y-C, Lu Y-P, Tseng R-C, et al. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. J Clin Invest. 2003; 111: 887-95

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp